ATE252552T1 - Hemmung von hiv-1 replikation mittels oligocarbamat-derivaten - Google Patents

Hemmung von hiv-1 replikation mittels oligocarbamat-derivaten

Info

Publication number
ATE252552T1
ATE252552T1 AT98933213T AT98933213T ATE252552T1 AT E252552 T1 ATE252552 T1 AT E252552T1 AT 98933213 T AT98933213 T AT 98933213T AT 98933213 T AT98933213 T AT 98933213T AT E252552 T1 ATE252552 T1 AT E252552T1
Authority
AT
Austria
Prior art keywords
rna
image
derivatives
oligocarbamate
oligocarbamates
Prior art date
Application number
AT98933213T
Other languages
English (en)
Inventor
Tariq M Rana
Ikramul Huq
Original Assignee
Univ New Jersey Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New Jersey Med filed Critical Univ New Jersey Med
Application granted granted Critical
Publication of ATE252552T1 publication Critical patent/ATE252552T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98933213T 1997-07-07 1998-07-07 Hemmung von hiv-1 replikation mittels oligocarbamat-derivaten ATE252552T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/888,865 US5843995A (en) 1997-07-07 1997-07-07 Inhibition of HIV-1 replication using oligocarbamate derivatives
PCT/US1998/014037 WO1999002488A1 (en) 1997-07-07 1998-07-07 Inhibition of hiv-1 replication using oligocarbamate derivatives

Publications (1)

Publication Number Publication Date
ATE252552T1 true ATE252552T1 (de) 2003-11-15

Family

ID=25394063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933213T ATE252552T1 (de) 1997-07-07 1998-07-07 Hemmung von hiv-1 replikation mittels oligocarbamat-derivaten

Country Status (7)

Country Link
US (1) US5843995A (de)
EP (1) EP0994850B1 (de)
AT (1) ATE252552T1 (de)
AU (1) AU8292198A (de)
CA (1) CA2296018C (de)
DE (1) DE69819154T2 (de)
WO (1) WO1999002488A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043332A2 (en) * 1999-01-25 2000-07-27 University Of Medicine And Dentistry Of New Jersey Biopolymers comprising human immunodeficiency virus tat
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
KR20020019126A (ko) * 1999-08-09 2002-03-09 트리펩 아베 트리펩티드를 함유하는 약학 조성물
US6420591B1 (en) 1999-10-04 2002-07-16 University Of Medicine And Dentistry Of New Jersey Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
AU2001269259A1 (en) * 2000-06-26 2002-01-08 Ribotargets Limited Aryl compounds, their preparation and their use in therapy
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
AU2003287217B2 (en) 2002-10-24 2010-03-04 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate RNA
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
EP1603546A1 (de) * 2003-02-21 2005-12-14 Tripep AB Glycinamid-derivat zur hemmung der hiv-replikation
ES2622062T3 (es) 2008-10-27 2017-07-05 Qiagen Gaithersburg, Inc. Ensayo y sistema de captura de híbrido de resultados rápidos
US9797000B2 (en) 2009-05-01 2017-10-24 Qiagen Gaithersburg Inc. Non-target amplification method for detection of RNA splice-forms in a sample
JP5826752B2 (ja) 2009-09-14 2015-12-02 キアジェン ゲイサーズバーグ インコーポレイテッド 細胞学用培地に固定された組織サンプルから核酸またはタンパク質を回収するための組成物および方法
IT1397569B1 (it) 2009-12-10 2013-01-16 Icgeb Peptidi e loro derivati che inibiscono il rilascio extracellulare della proteina tat di hiv-1 e la replicazione di hiv-1.
AU2011203450B2 (en) 2010-01-04 2016-01-07 Qiagen Gaithersburg, Inc. Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples
AU2011210748A1 (en) 2010-01-29 2012-08-09 Qiagen Gaithersburg, Inc. Method of determining and confirming the presence of HPV in a sample
JP6103941B2 (ja) 2010-01-29 2017-03-29 キアジェン ゲイサーズバーグ インコーポレイテッド 核酸の配列特異的精製および多重分析のための方法および組成物
AU2011255638B2 (en) 2010-05-19 2016-08-25 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
EP2678442B1 (de) 2011-02-24 2019-01-16 QIAGEN Gaithersburg, Inc. Materialien und verfahren für den nachweis von hpv-nukleinsäuren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576844A (en) * 1966-10-13 1971-04-27 Sumitomo Chemical Co N-alkoxycarbonyl-aminoalkyl guanidines
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
GB9511474D0 (en) * 1995-06-07 1995-08-02 Ciba Geigy Ag Antiviral peptoid compounds

Also Published As

Publication number Publication date
AU8292198A (en) 1999-02-08
DE69819154D1 (de) 2003-11-27
EP0994850A1 (de) 2000-04-26
US5843995A (en) 1998-12-01
WO1999002488A1 (en) 1999-01-21
CA2296018C (en) 2009-01-20
EP0994850B1 (de) 2003-10-22
DE69819154T2 (de) 2004-07-08
CA2296018A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
ATE252552T1 (de) Hemmung von hiv-1 replikation mittels oligocarbamat-derivaten
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
AP1853A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
PE20001403A1 (es) Derivados de pirrolidina como antagonistas del receptor ccr-3
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BR0016543A (pt) Novos derivados de piperidina e piperazina
ECSP066312A (es) Derivados piridilo y su uso como agentes terapéuticos
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
ES2063183T3 (es) Oligonucleotidos antisentido para la inhibicion de la secuencia diana del transactivador (tar) y de la sintesis de la proteina transactivadora (tat) de hiv-i y su uso.
ES2098790T3 (es) Derivados de 1,2,3,5,6,7,8,8a-octahidro-5,5,8a-trimetil-(8abeta)-6-isoquinoleinamina, su procedimiento de preparacion y su empleo en terapeutica.
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
DK0804437T3 (da) [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien
DE69637050D1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
NO20013517L (no) Makrolider med anti-inflammatorisk aktivitet
TR200000737T2 (tr) İkame edilmiş kroman türevleri.
TR199802384T2 (xx) N�rodejeneratif hastal�klar�n tedavisinde yararl� farmas�tik bile�imlerin haz�rlanmas� i�in P-Aminofenol t�revlerinin kullan�m�.
TR199701507T1 (xx) Kemik kayb�n�n asgariye d���r�lmesi i�in y�ntemler.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties